Paragraph 13 RepresentationI1

England, Wales and Scotland

Changes not yet applied. Later legislation changes this provision in ways not yet written into the text below:

Sch. rule 2 expiry of affecting provision Sch. rule 2 by General Pharmaceutical Council (Coronavirus) Rules 2021 Sch. rule 1(2)
Sch. rule 2A expiry of affecting provision Sch. rule 2 by General Pharmaceutical Council (Coronavirus) Rules 2021 Sch. rule 1(2)
Sch. rule 6(a) expiry of affecting provision Sch. rule 2 by General Pharmaceutical Council (Coronavirus) Rules 2021 Sch. rule 1(2)
Sch. rule 12(2)(b) expiry of affecting provision Sch. rule 2 by General Pharmaceutical Council (Coronavirus) Rules 2021 Sch. rule 1(2)
Sch. rule 12(2)(h) expiry of affecting provision Sch. rule 2 by General Pharmaceutical Council (Coronavirus) Rules 2021 Sch. rule 1(2)
Sch. rule 16(5) expiry of affecting provision Sch. rule 2 by General Pharmaceutical Council (Coronavirus) Rules 2021 Sch. rule 1(2)

(1)

The presenter must be a person who is—

(a)

a barrister, advocate or solicitor who falls within subparagraphs (i) or (ii) of article 61(2)(c) of the Order;

(b)

a solicitor in Scotland who does not fall within paragraph (a); or

(c)

an employee of the Council.

(2)

The appellant may be represented by a person who is—

(a)

a barrister, advocate or solicitor who falls within subparagraphs (i) or (ii) of article 61(2)(c) of the Order;

(b)

a solicitor in Scotland who does not fall within paragraph (a); or

(c)

a representative from the appellant’s defence organisation or the appellant’s trade union.

(3)

Where the appellant is not represented, the appellant may be accompanied and advised by a supporter, but the supporter—

(a)

may not be—

(i)

a member of the Council or of one of its statutory committees,

(ii)

an employee of the Council, or

(iii)

a witness at the hearing; and

(b)

will be entitled to address the Committee only with the permission of the chair.

Annotations